Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
University of Southern California, La Jolla, California UC San Diego Moores Cancer Center, La Jolla, California University of Minnesota Masonic Cancer Center, Minneapolis, Minnesota Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania M. D. Anderson Cancer Center, Houston, Texas